Comparison

ML385

Item no. V2828-250mg
Manufacturer InvivoChem LLC
CASRN 846557-71-9
Amount 250 mg
Quantity options 100 mg 10 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V2828CAS #:846557-71-9Purity >=98%

Description:ML-385 is a novel, potent and selective NRF2 inhibitor (Nrf2: nuclear factor E2 related factor 2) with an IC50 of 1.9 uM. ML385 interacts with NRF2 and affects the DNA binding activity of the NRF2-MAFG protein complex. The addition of ML385 decreases anisotropy dose-dependently. ML-385 selectively intervenes therapeutic resistance in KEAP1-Deficient NSCLC Tumors. It acts by inhibiting the downstream target gene expression of NRF2. ML385 in combination with chemotherapeutic agents such as carboplatin showed significant tumor-suppression activity.

References: 2016 Nov 18; 11(11):3214-3225. Epub 2016 Oct 17.

Molecular Weight (MW)
511.60
Formula
C29H25N3O4S
CAS No.
846557-71-9
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: >= 30 mg/mL
Water: N/A
Ethanol: N/A
SMILES
O=C(NC1=NC(C2=CC=C(N(C(C3=C(C)C=CC=C3)=O)CC4)C4=C2)=C(C)S1)CC5=CC(OCO6)=C6C=C5
Synonyms

ML385; ML 385; ML-385

Exact Mass: 511.1566

Chemical Name: N-[4-[2, 3-dihydro-1-(2-methylbenzoyl)-1H-indol-5-yl]-5-methyl-2-thiazolyl]-1, 3-benzodioxole-5-acetamide

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 250 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close